Quick Dispatch:
Your glp-1/glucagon dual receptor agonist Doer Biologics published paper of a long-acting GLP-1R / GCGR dual-agonist for the treatment of diabetes and obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1/glucagon dual receptor agonist Doer Biologics published paper of a long-acting GLP-1R / GCGR dual-agonist for the treatment of diabetes and obesity ships.
Need Help?
Questions about glp-1/glucagon dual receptor agonist Doer Biologics published paper of a long-acting GLP-1R / GCGR dual-agonist for the treatment of diabetes and obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1/glucagon dual receptor agonist Doer Biologics published paper of a long-acting GLP-1R / GCGR dual-agonist for the treatment of diabetes and obesity in your area.
PDB-101: Molecule of the Month: GLP-1 Receptor Agonists
21.49
New strategies for the treatment of obesity and metabolic dysfunctions
28.88
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations
21.60
Effects, working principles and target tissues of dual agonists
23.29
Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes
20.06
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
21.27
Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review
29.03
